Gastrointestinal bleeding

Endoscopy

Volumn 41, Issue 10, 2009, Pages 866-871

  Cipolletta, L ^a   Rotondano, G ^a   Bianco, M A ^a  

^a Hospital Maresca   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR;

DRUG EFFICACY; ENDOSCOPY; ESOPHAGUS VARICES; GASTROINTESTINAL HEMORRHAGE; HEMOSTASIS; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; UPPER GASTROINTESTINAL BLEEDING;

ANTICOAGULANTS; ENDOSCOPY, GASTROINTESTINAL; GASTROINTESTINAL HEMORRHAGE; HUMANS; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 70349680950     PISSN: 0013726X     EISSN: 14388812     Source Type: Journal    
DOI: 10.1055/s-0029-1215128     Document Type: Review

References (84)

1. Gururatsakul M, Ching K J., Talley N J., et al. Incidence and risk factors of uncomplicated peptic ulcer and bleeding peptic ulcer over a 10-year period. Gastrointest Endosc 2009 69 AB607
2. Karsan S S., Kanwal F, Huang E S., et al. Early endoscopy predicts lower mortality in acute gastrointestinal haemorrhage. Gastroenterology 2009 136 (5 Suppl 1) A606
3. Marmo R, Rotondano G, Cipolletta L, et al. Artificial neural network vs. Rockall score for prediction of mortality in patients with non variceal upper gastrointestinal bleeding. Gastrointest Endosc 2009 69 AB119
4. Wyse J M., Barkun A N., Bardou M, et al. Can the presence of endoscopic high-risk stigmata be confidently predicted before gastroscopy? Gastrointest Endosc 2009 69 AB181
5. Cipolletta L, Rotondano G, Bianco M A., et al. Magnification endoscopy can help in improving characterization of visible vessels in peptic ulcer bleeding: a pilot study. Gastrointest Endosc 2009 69 AB119
6. Pang S H., Tsoi K K., Ching J, et al. Prediction of the need for endoscopic haemostasis in upper gastrointestinal haemorrhage (UGIH): a risk score derivation and validation study. Gastrointest Endosc 2009 69 AB177
7. Sung J J., Barkun A N., Kuipers E J., et al. Effect of type of endoscopic haemostasis and adjuvant intravenous esomeprazole on peptic ulcer re-bleeding. Gastrointest Endosc 2009 69 AB617
8. Park P O., Rothstein R I., Vassiliou M C., et al. A randomized study comparing haemostasis of laparoscopic clips delivered via flexible endoscopy versus conventional endoscopic clips on porcine mesenteric vessels. Gastrointest Endosc 2009 69 AB163
9. Giday S A., Kim Y, Krishnamurty D M., et al. A long-term randomized controlled trial of a novel nanopowder hemostatic agent for control of severe upper gastrointestinal bleeding in a porcine model. Gastrointest Endosc 2009 69 AB133
10. Chiu P W., Joeng H, Choi C, et al. Scheduled 2nd endoscopy or high dose omeprazole infusion in preventing peptic ulcer rebleeding a prospective randomized trial. Gastroenterology 2009 136 (5, suppl 1) A43
11. Barkun A N., Sung J J., Kuipers E J., et al. Intravenous esomeprazole for prevention of peptic ulcer re-bleeding in a predominantly caucasian population: results on clinical benefits and hospital resource use. Gastroenterology 2009 136 (5 Suppl 1) A43
12. Sreedharan A, Martin J, Leontiadis G I., et al. Does proton pump inhibitor (PPI) treatment initiated before endoscopy work in unselected upper gastrointestinal bleeding? A Cochrane systematic review update. Gastroenterology 2009 136 (5 Suppl 1) A44
13. Barkun A N., Bardou M, Gralnek I M., et al. Impact of elevated INR and of low platelet count on outcomes in acute upper GI bleeding (UGIB). Gastroenterology 2009 136 (5 Suppl 1) A605
14. Ortiz V, Ortuno J A., Soler M R., et al. Is really the clinical outcome of non-variceal acute upper gastrointestinal bleeding different in anticoagulated patients. Gastroenterology 2009 136 (5 Suppl 1) A608
15. Barkun A N., Bardou M, Gralnek I A., et al. Erythromycin and other prokinetics in acute upper gastrointestinal bleeding? A meta-analysis. Gastroenterology 2009 136 (5 Suppl 1) A636
16. Calvet X, Barkun A N., Kuipers E J., et al. Is H. pylori testing clinically useful in the acute setting of upper gastrointestinal bleeding? A systematic review. Gastroenterology 2009 136 (5 Suppl 1) A6
17. Torres G J., Flores R endon F, Leal-Salazar J, et al. The ChildPugh C score and NSAIDs use as risk factors for five day mortality in cirrhotic patients with non-variceal bleeding. Gastroenterology 2009 136 (5 Suppl 1) A416
18. Kantsevoy S V., Dray X, Donatelli G, et al. EUS-guided selective embolization of splenic vein and its branches: A new therapeutic option for variceal bleeding. Gastrointest Endosc 2009 69 AB325
19. Chan F KL, Ching J, Au K WL, et al. What is the risk of recurrent lower gastrointestinal bleeding with continued low-dose aspirin therapy? An 8-year prospective cohort study. Gastroenterology 2009 136 (5 Suppl 1) A68
20. Jensen D M., Ohning G V., Kovacs T O., et al. Doppler ultrasound probe (DUP) for risk stratification and endoscopic haemostasis of bleeding colonic lesions. Gastrointest Endosc 2009 69 AB289
21. Gaddam S, OBrien J, Trottier S J. Apache II score as a predictor of mortality in ICU in gastrointestinal bleed (GIB) patients. Gastroenterology 2009 136 (5 Suppl 1) A635
22. Brullet E, Calvet X, Campo R, et al. Clinical judgement versus risk scores for predicting outcome in patients bleeding from high risk peptic ulcer. Preliminary results of a prospective multicenter study. Gastroenterology 2009 136 (5 Suppl 1) A43-A44
23. Jensen D M., Stuart R, Ahlbom H, et al. Inter-observer agreement on assessment of photo documentation in bleeding peptic ulcer. Gastrointest Endosc 2009 69 AB186
24. Jensen D M., Stuart R, Ahlbom H, et al. Is there a subgroup of patients with Forrest Ib (oozing) peptic ulcer bleeding at increased risk of re-bleeding? Gastrointest Endosc 2009 69 AB118
25. Tellez-Avila F I., Chavez-Tapia N C., López-Arce G, et al. Utility of a new simplified predictive model for predict rebleeding in patients with high-risk stigmata ulcers. Gastrointest Endosc 2009 69 AB185
26. Nam J H., Kim J H., Ahn J S., et al. Can we predict the rebleeding within a week after emergent and successful endoscopic haemostasis according to the patterns of non-variceal upper gastrointestinal bleeeding? A multicenter study. Gastrointest Endosc 2009 69 AB176
27. Torres J O., Flores R endon R, Sandoval M C., et al. Clinical features and risk factors for three-day mortality in elderly patients with non variceal bleeding. Gastroenterology 2009 136 (5 Suppl 1) A607
28. Lim L G., Lim L L., Teoh P L., et al. Factors associated with mortality in non-variceal and variceal upper gastrointestinal bleed: experience in an Asian tertiary hospital. Gastroenterology 2009 136 (5 Suppl 1) A608
29. de Melo S W., Guerriero R, Bhore R, et al. Predicting the cause of upper gastrointestinal haemorrhage: does clinical experience matter? Gastroenterology 2009 136 (5 Suppl 1) A637
30. Suk K T., Kim H S., Kim H J., et al. Risk factors of rebleeding following endoscopic therapy for nonvariceal upper gastrointestinal haemorrhage. Gastrointest Endosc 2009 69 AB214
31. de Melo S W., Guerrero R, Bhore R, et al. Predicting the need for endoscopic therapy in patients with upper gastrointestinal haemorrhage using clinical features. Gastrointest Endosc 2009 69 AB313-AB314
32. Saltzman J R., Stenson T H., Thiesen A, et al. Optimizing monopolar coagulation therapy for non-variceal upper gastrointestinal bleeding. Gastrointest Endosc 2009 69 AB118
33. Arima S, Ogata S, Tominaga N, et al. Endoscopic haemostasis with high-frequency soft coagulation for bleeding gastric ulcer: comparison with metallic hemoclips in a prospective, randomized study. Gastrointest Endosc 2009 69 AB617
34. Andriulli A, Loperfido S, Fornari F, et al. Endoscopic dual versus monotherapy in patients bleeding from high-risk peptic ulcers. Gastrointest Endosc 2009 69 AB205
35. Tseng G. Role of endoscopic therapy plus intravenous proton pump inhibitor in uremic patients with high-risk peptic ulcer bleeding preliminary report of a case-controlled study. Gastrointest Endosc 2009 69 AB179-AB180
36. Barkun A N., Wyse J M., Romagnuolo J, et al. Should we be performing routine second-look endoscopy in acute peptic ulcer bleeding in 2009? A meta- analysis. Gastrointest Endosc 2009 69 AB180
37. Barkun A N., Teich V, Gralnek I M., et al. The introduction of pre-endoscopy (EGD) high-dose intravenous proton pump inhibition (HDIVPPI) in the management of patients with acute upper gastrointestinal bleeding (UGIB) a budget impact analysis. Gastroenterology 2009 136 (5 Suppl 1) A63444
38. Torres J O., Flores R endon R, Sandoval M C., et al. Use of proton pump inhibitors on admission is a protective factor for three day-mortality in non-variceal bleeding (NVB). Gastroenterology 2009 136 (5 Suppl 1) A607
39. Prakash R, Iduru S V., Shah N R., et al. Pre-endoscopic proton pump inhibitors in non-variceal upper gastrointestinal bleeding; continuous infusion vs. bolus. Gastroenterology 2009 136 (5 Suppl 1) A608
40. Leontiadis G I., Martin J, Sharma V K., et al. Proton pump inhibitor (PPI) treatment for peptic ulcer (PU) bleeding: an updated Cochrane meta-analysis of randomized controlled trials. Gastroenterology 2009 136 (5 Suppl 1) A605
41. Cheng H C., Yang H B., Chang W L., et al. Prolonged low-dose omeprazole infusion for 7 days can reduce peptic ulcer re-bleeding for high-risk co-morbid patients. Gastroenterology 2009 136 (5 Suppl 1) A43
42. Henry M J., Puchakayala B K., Raghavendra M, et al. Retrospective comparison of oral vs. intravenous proton-pump inhibitor therapy in patients with acute peptic ulcer bleeding and high-risk endoscopic stigmata. Gastroenterology 2009 136 (5 Suppl 1) A608
43. Yachimski P S., Farrell E, Daniel H unt D, et al. Proton pump inhibitors for prophylaxis of nosocomial upper gastrointestinal bleeding: the impact of standardized guidelines on prescribing practice. Gastroenterology 2009 136 (5 Suppl 1) A636
44. Vinogradova Y, Leighton M, Avery A, et al. Increased aspirin use and upper gastrointestinal bleeding rates in socially deprived patients. Gastroenterology 2009 136 (5 Suppl 1) A69
45. Leighton M, Vinogradova Y, Shonde A, et al. Diagnostic precision of primary care electronic database for study of gastrointestinal bleeding and its ability to detect the influence of aspirin. gastroenterology 2009 136 (5 Suppl 1) A612
46. Cannon M D., Doherty G A., Murray F E. Are undergraduate medical students aware of the risks of upper gastrointestinal haemorrhage associated with commonly prescribed medications? Gastroenterology 2009 136 (5 Suppl 1) A637
47. Doherty G A., Cannon M D., Lynch K M., et al. Risk assessment in the co-prescription of PPIs for gastroprotection: an analysis of what we do and what we think we do. Gastroenterology 2009 136 (5 Suppl 1) A606
48. Bretagne J, Nalet B, Lesur G, et al. The prevention of upper gastrointestinal bleeding associated with antiplatelet therapy by proton pump inhibitors (PPI). results of a nested casecontrol study. Gastroenterology 2009 136 (5 Suppl 1) A634
49. Bretagne J, Nalet B, Lesur G, et al. Gastrointestinal bleeding (GIB) and antiplatelet therapy (APT). A French national observational survey including 1010 patients in the hospital setting. Comparison of the results based on the origin of the patients (academic hospital (AH) or community hospital (Ch). Gastroenterology 2009 136 (5 Suppl 1) A635
50. John B K., Arramraju S, Shalomov A, et al. The use of antiplatelet agents does not impact the hospital course of patients admitted with GI bleed. Gastroenterology 2009 136 (5 Suppl 1) A634
51. Takada J, Araki H, Onogi F, et al. A study on emergency gastro-intestinal endoscopic haemostasis related to anti platelet drugs, anti thrombosis drugs, and non-steroidal anti-inflammatory drugs (NSAIDs). Gastrointest Endosc 2009 69 AB182-AB183
52. Ali M A., Chaudhry S, Farooq F T. Acute gastrointestinal bleeding (GIB) in the setting of warfarin use and supratherapeutic INR (ST-INR): frequency of significant endoscopic findings (EF) and independent predictors of GIB. Gastrointest Endosc 2009 69 AB174
53. Bretagne J, Nalet B, Lesur G, et al. Characteristics of upper and lower gastrointestinal bleeding associated with antiplatelet therapy (APT). Are there any differences between aspirin and clopidogrel treatment? Gastroenterology 2009 136 (5 Suppl 1) A634
54. Bardou M, Fourrier-Róglat A, Nicholas M, et al. Why do patients at increased risk for gastrointestinal (GI) complication receive ketoprofen despite its poor GI safety profile?: analysis of two databases in Canada and France. Gastroenterology 2009 136 (5 Suppl 1) A635
55. Martin J, Connelly S E., Tsui E, et al. Proton pump inhibitors versus H2-receptor antagonists for stress ulcer prophylaxis in mechanically ventilated intensive care patients: a meta-analysis. Gastroenterology 2009 136 (5 Suppl 1) A636
56. Calvet X, Barkun A N., Kuipers E J., et al. Is H. pylori testing clinically useful in the acute setting of upper gastrointestinal bleeding? A systematic review. Gastroenterology 2009 136 (5 Suppl 1) A605
57. Atreja A, Suchdev K, Vargo J J. Screening for Helicobacter pylori in hospitalized patients with peptic ulcer haemorrhage: are we missing the boat? Gastroenterology 2009 136 (5 Suppl 1) A606
58. Guardiola J, Botargues J M., Berrozpe A, et al. Gastric lavages versus intravenous erythromycin prior to urgent endoscopy for acute upper gastrointestinal bleeding. a randomized trial. Gastrointest Endosc 2009 69 AB186
59. Karsan S S., Kanwal F, Huang E S., et al. Does the completion of nasogastric lavage (NGL) improve outcomes in GI haemorrhage? Gastroenterology 2009 136 (5 Suppl 1) A607
60. Sharma R, Olafsson S, Jackson C S. Clinical presentation and outcomes of MalloryWeiss syndrome: A VA experience. Gastroenterology 2009 136 (5 Suppl 1) A608
61. Manabe N, Hata J, Haruma K, et al. Active gastrointestinal bleeding: detection and localization with contrast-enhanced ultrasonography. Gastroenterology 2009 136 (5 Suppl 1) A44
62. Park K S., Cho K. Therapeutic efficacy of superselective arterial embolization in patients with gastrointestinal haemorrhage. Gastroenterology 2009 136 (5 Suppl 1) A645
63. Flierman A, Kleibeuker J H., Koornstra J J. The incidence of upper gastrointestinal bleeding complications following open heart surgery. Gastroenterology 2009 136 (5 Suppl 1) A606
64. Jafri S R., Biswas J, Arora G, et al. Utility and safety of endoscopic procedures in neutropenic patients with gastrointestinal bleeding. Gastrointest Endosc 2009 69 AB313
65. Balderas V, Lara L F., Sreenarasimhaiah J, et al. Endoscopy is safe in patients with upper gastrointestinal haemorrhage and low hematocrit. Gastrointest Endosc 2009 69 AB310
66. Okanobu H, Tanaka T, Ohya T. A role of colonoscopy in patients with acute lower gastrointestinal bleeding. Gastrointest Endosc 2009 69 AB302
67. Bretagne J, Nalet B, Lesur G, et al. Characteristics of upper and lower gastrointestinal bleeding associated with antiplatelet therapy (APT). Are there any differences between aspirin and clopidogrel treatment? Gastroenterology 2009 136 (5 Suppl 1) A634
68. Correa P, Averbach M, Paccos J, et al. Endoscopic management of massive acute lower gastrointestinal bleeding. Gastrointest Endosc 2009 69 AB288
69. Correa P, Lobo E J., Averbach M, et al. Efficacy and safety of argon plasma coagulation for the treatment of hemorrhagic radiation proctitis. Gastrointest Endosc 2009 69 AB279-AB230
70. Duraiswamy S, Schmulewitz N, Rockey D C. The role of technetium-99 labeled erythrocyte scintigraphy in the evaluation of patients with lower gastrointestinal haemorrhage. Gastrointest Endosc 2009 69 AB284
71. Lyles T E., Naik S, Rockey D C. Outcomes in cirrhotics with upper gastrointestinal haemorrhage importance of the etiology of bleeding. Gastroenterology 2009 136 (5 Suppl 1) A825
72. Gana J C., Turner D, Avitzur Y, et al. Prediction of esophageal variceal bleeding in children. Gastroenterology 2009 136 (5 Suppl 1) A825
73. Satoskar R S., Mayorga C A., Reddy K G., et al. Adherence to standard of care measures in suspected acute variceal bleeding. Gastroenterology 2009 136 (5 Suppl 1) A825
74. Stein L L., Mazhar S M., Gabbert C, et al. Esophageal variceal band ligation (EVL) plus beta-blocker (BB) treatment in the primary prophylaxis of esophageal variceal bleeding. Gastroenterology 2009 136 (5 Suppl 1) A826
75. Iwase H, Shimada M, Hirashima N, et al. Long-term endoscopic obliteration with cyanoacrylate glue for isolated gastric variceal bleeding a 15-year prospective evaluation. Gastrointest Endosc 2009 69 AB119
76. Lee J W., Kim H, Park J H., et al. Oral ciprofloxacin versus intravenous ceftriaxone in the prophylaxis of infections in patients with decompensated liver cirrhosis and gastrointestinal haemorrhage preliminary result. Gastroenterology 2009 136 (5 Suppl 1) A824
77. Cardenas A, Pritchett S, Brown R S., et al. The effects of long term PEG-interferon therapy on the development of esophageal varices and variceal bleeding in patients with hepatitis C and advanced fibrosis: final results from the copilot trial. Gastroenterology 2009 136 (5 Suppl 1) A795
78. Somsouk M, Aslam R, Ali M, et al. Esophageal varices on computed tomography predicts variceal haemorrhage. Gastrointest Endosc 2009 69 AB355-AB356
79. Moodley J, Lopez R, Carey W D. The impact of practice guideline (PG) compliance on prevention of first esophageal variceal haemorrhage. (EVH) in patients with cirrhosis a validation study. Gastroenterology 2009 136 (5 Suppl 1) A824
80. Nguyen K C., Nguyen T H. Efficacy of endoscopic multi-site band ligation in eradicating esophageal varices. Gastrointest Endosc 2009 69 AB222
81. DellEra A, Iannuzzi F, Fabris F M., et al. Influence of portal vein thrombosis (PVT) on the efficacy of variceal band ligation. Gastroenterology 2009 136 (5 Suppl 1) A825
82. Miyata Y, Furuichi Y, Ichimura S, et al. Safe injection method for a cyanoacrylate monomer (CA) in the treatment of gastric fundal variceal rupture. Gastrointest Endosc 2009 69 AB261-AB262
83. Safwat W. The use of N-2-butyl cyanoacrylate as a rescue therapy for re-bleeding and uncontrollable bleeding from esophageal varices. Gastrointest Endosc 2009 69 AB118-AB119
84. Cheung J, Zeman M, van Zanten S V., et al. A systematic review and meta-analysis of secondary prophylaxis with band ligation, pharmacotherapy or combination therapy after esophageal variceal bleeding. Gastrointest Endosc 2009 69 AB284